Stocks · News reference
Filed: 2026-10-01 AccNo: 0001193125-26-410781 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Achieve Life Sciences presented 52-week data for its cytisinicline program, which is being developed as a treatment for nicotine dependence, at the CHEST 2026 annual meeting.